4 Results for "

N-terminal ATP binding domain

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "N-terminal ATP binding domain" in MCE Product Catalog:

2
2 Cited Publications
Cat. No.: HY-106723A
CAS No.: 7414-56-4
Purity:  99.29%
Target:  

HSP

Research Areas:  

Cancer

AMP-PCP disodium is an ATP analogue and can bind to Hsp90 N-terminal domain with a Kd value of 3.8 μM. AMP-PCP disodium binding favors the formation of the active homodimer of Hsp90 .
loading...
    loading...
Cat. No.: HY-106723
CAS No.: 3469-78-1
Target:  

HSP

Research Areas:  

Cancer

AMP-PCP is an ATP analogue and can bind to Hsp90 N-terminal domain with a Kd value of 3.8 μM. AMP-PCP binding favors the formation of the active homodimer of Hsp90 .
loading...
    loading...
Cat. No.: HY-W286614
CAS No.: 62001-32-5
Research Areas:  

Inflammation/Immunology Cancer

RSK2-IN-4 (Compound 10) is a RSK2 inhibitor, with an inhibition rate of 13.73% on RSK2 activity at 10 μM. RSK2-IN-4 binds to the ATP-binding site of RSK2 in the NTKD (N-terminal kinase domain), with the electron-donating group at the 4-position of the phenyl ring being the key determinant for its inhibitory activity .
loading...
    loading...
Cat. No.: HY-111300
CAS No.: 848952-37-4
Target:  

HSP EGFR

Research Areas:  

Cancer

G3130 is a reversible HSP90 inhibitor with a Kd value of 280 nM for the N-terminal ATP-binding domain of purified human Hsp90α. G3130 binds to the adenine site via a multi-hydrogen bond network . G3130 induces the degradation of Hsp90 client protein Her-2 in breast cancer cells. G3130 activates Hsp70 promoter-driven luciferase expression in 293T cells. G3130 can be used in breast cancer-related research .
loading...
    loading...